Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.95 EUR | +2.14% | 0.00% | -6.27% |
Mar. 14 | Hyloris Pharmaceuticals SA Provides Earnings Guidance for 2024 | CI |
Mar. 14 | Transcript : Hyloris Pharmaceuticals SA, 2023 Earnings Call, Mar 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.27% | 358M | |
+25.61% | 660B | |
+25.87% | 562B | |
-5.24% | 358B | |
+16.49% | 322B | |
+8.28% | 297B | |
+7.09% | 219B | |
-9.12% | 196B | |
+5.01% | 199B | |
-8.75% | 149B |
- Stock Market
- Equities
- HYL Stock
- News Hyloris Pharmaceuticals SA
- Hyloris Pharmaceuticals : Secures Licensing Deal for Rhoshan's Intravenous Acetylsalicylic Acid in US